Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancer

Cancer Letters

Volumn 205, Issue 2, 2004, Pages 173-180

  Jung, Klaus ^a   Stephan, Carsten ^a   Lewandowski, Michaela ^a   Klotzek, Silke ^a   Jung, Monika ^a   Kristiansen, Glen ^a   Lein, Michael ^a   Loening, Stefan A ^a   Schnorr, Dietmar ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Benign prostatic hyperplasia; Metastasis; Plasma DNA; Prostate cancer; Survival

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CELL FREE SYSTEM; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FOLLOW UP; HUMAN; HUMAN CELL; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; VALIDATION PROCESS;

EID: 1242316176     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2003.11.023     Document Type: Article

References (29)

1. Anker P., Mulcahy H., Stroun M. Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies? Int. J. Cancer. 103:2003;149-152.
2. Stroun M., Anker P., Maurice P., Lyautey J., Lederrey C., Beljanski M. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology. 46:1989;318-322.
3. Nawroz H., Koch W., Anker P., Stroun M., Sidransky D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat. Med. 2:1996;1035-1037.
4. Kopreski M.S., Benko F.A., Borys D.J., Khan A., McGarrity T.J., Gocke C.D. Somatic mutation screening: identification of individuals harboring K-ras mutations with the use of plasma DNA. J. Natl Cancer Inst. 92:2000;918-923.
5. Lecomte T., Berger A., Zinzindohoue F., Micard S., Landi B., Blons H., et al. Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis. Int. J. Cancer. 100:2002;542-548.
6. Johnson P.J., Lo Y.M. Plasma nucleic acids in the diagnosis and management of malignant disease. Clin. Chem. 48:2002;1186-1193.
7. Ziegler A., Zangemeister-Wittke U., Stahel R.A. Circulating DNA: a new diagnostic gold mine? Cancer Treat. Rev. 28:2002;255-271.
8. Jeronimo C., Nomoto S., Caballero O.L., Usadel H., Henrique R., Varzim G., et al. Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene. 20:2001;5195-5198.
9. Goessl C., Müller M., Straub B., Miller K. DNA alterations in body fluids as molecular tumor markers for urological malignancies. Eur. Urol. 41:2002;668-676.
10. Jernimo C., Usadel H., Henrique R., Silva C., Oliveira J., Lopes C., Sidransky D. Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer. Urology. 60:2002;1131-1135.
11. Wu T.L., Zhang D., Chia J.H., Tsao K.H., Sun C.F., Wu J.T. Cell-free DNA: measurement in various carcinomas and establishment of normal reference range. Clin. Chim. Acta. 321:2002;77-87.
12. Goessl C., Müller M., Miller K. Methylation-specific PCR (MSP) for detection of tumour DNA in the blood plasma and serum of patients with prostate cancer. Prostate Cancer Prostatic Dis. 3:2000;S17.
13. Lo Y.M., Tein M.S., Lau T.K., Haines C.J., Leung T.N., Poon P.M., et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am. J. Hum. Genet. 62:1998;768-775.
14. Lee T.H., Montalvo L., Chrebtow V., Busch M.P. Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma. Transfusion. 41:2001;276-282.
15. Lui Y.Y., Chik K.W., Chiu R.W., Ho C.Y., Lam C.W., Lo Y.M. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin. Chem. 48:2002;421-427.
16. Meyer A., Jung K., Lein M., Schnorr D., Loening S.A. Factors influencing the ratio of free to total prostate specific antigen in serum. Int. J. Cancer. 74:1997;630-636.
17. Chiu R.W., Poon L.L., Lau T.K., Leung T.N., Wong E.M., Lo Y.M. Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin. Chem. 47:2001;1607-1613.
18. Swinkels D.W., Wiegerinck E., Steegers E.A.P., de Kok J.B. Effects of blood-processing protocols on cell-free DNA quantification in plasma. Clin. Chem. 49:2003;525-526.
19. Jung M., Klotzek S., Lewandowski M., Fleischhacker M., Jung K. Changes in concentration of DNA in serum and plasma during storage of blood samples. Clin. Chem. 49:2003;1028-1029.
20. Vitzthum F., Geiger G., Bisswanger H., Brunner H., Bernhagen J. A quantitative fluorescence-based microplate assay for the determination of double-stranded DNA using SYBR Green I and a standard ultraviolet transilluminator gel imaging system. Anal. Biochem. 276:1999;59-64.
21. Jung K., Stephan C., Lein M., Henke W., Schnorr D., Brux B., et al. Analytical performance and clinical validity of two free prostate-specific antigen assays compared. Clin. Chem. 42:1996;1026-1033.
22. Jung K., Lein M., von Hösslin K., Brux B., Schnorr D., Loening S.A., Sinha P. Osteoprotegerin in serum as novel marker of bone metastatic spread in prostate cancer. Clin. Chem. 47:2001;2061-2063.
23. Solberg H.E. Approved recommendations (1987) on the theory of reference values. Part 5. Statistical treatment of collected reference values. Determinations of reference limits. J. Clin. Chem. Clin. Biochem. 25:(1987):1987;645-656.
24. de Kok J.B., Hendriks J.C., van Solinge W.W., Willems H.L., Mensink E.J., Swinkels D.W. Use of real-time quantitative PCR to compare DNA isolation methods. Clin. Chem. 44:1998;2201-2204.
25. Dixon S.C., Horti J., Guo Y., Reed E., Figg W.D. Methods for extracting and amplifying genomic DNA isolated from frozen serum. Nat. Biotechnol. 16:1998;91-94.
26. Thijssen M.A., Swinkels D.W., Ruers T.J., de Kok J.B. Difference between free circulating plasma and serum DNA in patients with colorectal liver metastases. Anticancer Res. 22:2002;421-425.
27. Leon S.A., Shapiro B., Sklaroff D.M., Yaros M.J. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 37:1977;646-650.
28. Fournie G.J., Courtin J.P., Laval F., Chale J.J., Pourrat J.P., Pujazon M.C., et al. Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett. 91:1995;221-227.
29. Jahr S., Hentze H., Englisch S., Hardt D., Fackelmayer F.O., Hesch R.D., Knippers R. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 61:2001;1659-1665.